Cardiac Troponin I and Gender Hormone Therapy

A NEW prospective study found that 12 months of gender-affirming hormone therapy (GAHT) shifts levels of Cardiac Troponin I in transgender adults toward their affirmed gender, suggesting potential effects of GAHT on cardiac mass or…